MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, NAGE has $114,329K in assets. $31,999K in debts.

Balance Sheets Overview

Current Ratio
460.57%
Quick Ratio
355.35%
Debt to Asset Ratio
27.99%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents, inclu...
    • Trade receivables, net of allowa...
    • Intangible assets, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents, including restricted cash of 152 for both periods presented
66,549 64,788 64,290 60,474
Trade receivables, net of allowances of 176 and 147, respectively
13,068 9,741 8,506 9,656
Inventories
24,016 20,424 18,791 14,406
Assets held for sale
0 541 --
Prepaid expenses and other assets
1,488 1,312 2,029 2,143
Total current assets
105,121 96,806 93,616 86,679
Leasehold improvements and equipment, net
1,298 1,323 1,499 1,632
Intangible assets, net
5,485 5,660 246 284
Right-of-use assets, net
2,019 2,192 2,361 2,525
Other long-term assets
406 425 417 405
Total assets
114,329 106,406 98,139 91,525
Accounts payable
13,277 10,796 12,742 13,680
Accrued expenses
7,621 7,722 8,700 7,381
Current maturities of operating lease obligations
1,032 1,002 976 957
Current maturities of finance lease obligations
-0 2 6
Current deferred consideration liability
514 ---
Customer deposits
380 399 292 303
Total current liabilities
22,824 19,919 22,712 22,327
Deferred revenue
2,572 2,674 2,674 2,674
Operating lease obligations, less current maturities
1,544 1,815 2,077 2,329
Deferred consideration liability, less current portion
5,059 5,465 --
Total liabilities
31,999 29,873 27,463 27,330
Common stock, 0.001 par value authorized 150,000 shares 79,457 shares and 79,714 shares issued and outstanding at march31, 2026 and december31, 2025, respectively
79 79 79 79
Additional paid-in capital
240,464 240,991 239,266 237,358
Accumulated deficit
-158,210 -164,528 -168,660 -173,238
Cumulative translation adjustments
-3 -9 -9 -4
Total stockholders' equity
82,330 76,533 70,676 64,195
Total liabilities and stockholders' equity
114,329 106,406 98,139 91,525
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents, including...$66,549K Inventories$24,016K Trade receivables,net of allowances of...$13,068K Prepaid expenses andother assets$1,488K Total current assets$105,121K Intangible assets, net$5,485K Right-of-use assets, net$2,019K Leasehold improvementsand equipment, net$1,298K Other long-termassets$406K Total assets$114,329K Total liabilities andstockholders' equity$114,329K Total stockholders'equity$82,330K Total liabilities$31,999K Accumulated deficit-$158,210K Cumulative translationadjustments-$3K Additional paid-in capital$240,464K Total currentliabilities$22,824K Deferred considerationliability, less current...$5,059K Deferred revenue$2,572K Operating leaseobligations, less current...$1,544K Common stock, 0.001 parvalue authorized...$79K Accounts payable$13,277K Accrued expenses$7,621K Current maturities ofoperating lease...$1,032K Current deferredconsideration liability$514K Customer deposits$380K

Niagen Bioscience, Inc. (NAGE)

Niagen Bioscience, Inc. (NAGE)